Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Stock indices matter because they summarize broad market performance, guide diversification, and influence risk assessments for investors.
27,507 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
When blue-chip allocators signal interest in a landmark IPO, it reshapes how individual investors view the stock. Thi...
OpenAI just signaled might delay its IPO, sending ripples through AI investors and chipmakers. This guide breaks down...
Navigator (NVGS) 2025 earnings paint a picture of a niche LNG carrier operator balancing utilization, rates and lever...
Micron Technology stunned investors with a massive quarterly upside. This article breaks down why micron technology's...
Apple's dependable cash flow and dividends meet a challenging, transforming Tesla. As 2026 unfolds, investors weigh w...
IBM stock slides as Anthropic's AI code tool threatens IBM's COBOL modernization business, forcing investors to repri...
Copper prices sit near multi-month highs in March 2026, and investors are eyeing a Chile-focused ETF as a clean coppe...
Super Micro Computer jumped 5% after posting a margin beat and raised guidance. The move fans the debate over a poten...
NVIDIA posted blockbuster results that reinforce its AI data center leadership, but the stock faces a rocky road as h...
Tilray has cleared several hurdles, but a true breakout depends on one pivotal development. This guide breaks down th...
Two very different consumer stocks sit at the crossroads of retail: American Eagle Outfitters and Chewy. This analysi...